These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 20074001)

  • 41. Factors to consider in the use of stem cells for pharmaceutic drug development and for chemical safety assessment.
    Trosko JE; Chang CC
    Toxicology; 2010 Mar; 270(1):18-34. PubMed ID: 19948204
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In silico-aided prediction of biological properties of chemicals: oestrogen receptor-mediated effects.
    Roncaglioni A; Benfenati E
    Chem Soc Rev; 2008 Mar; 37(3):441-50. PubMed ID: 18224255
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comprehension of drug toxicity: software and databases.
    Toropov AA; Toropova AP; Raska I; Leszczynska D; Leszczynski J
    Comput Biol Med; 2014 Feb; 45():20-5. PubMed ID: 24480159
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structural alerts--a new classification model to discriminate excess toxicity from narcotic effect levels of organic compounds in the acute daphnid assay.
    von der Ohe PC; Kühne R; Ebert RU; Altenburger R; Liess M; Schüürmann G
    Chem Res Toxicol; 2005 Mar; 18(3):536-55. PubMed ID: 15777094
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development and validation of k-nearest-neighbor QSPR models of metabolic stability of drug candidates.
    Shen M; Xiao Y; Golbraikh A; Gombar VK; Tropsha A
    J Med Chem; 2003 Jul; 46(14):3013-20. PubMed ID: 12825940
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The challenge of predicting drug toxicity in silico.
    Vedani A; Dobler M; Lill MA
    Basic Clin Pharmacol Toxicol; 2006 Sep; 99(3):195-208. PubMed ID: 16930291
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolism and toxicity of drugs. Two decades of progress in industrial drug metabolism.
    Baillie TA
    Chem Res Toxicol; 2008 Jan; 21(1):129-37. PubMed ID: 18052111
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hologram QSAR model for the prediction of human oral bioavailability.
    Moda TL; Montanari CA; Andricopulo AD
    Bioorg Med Chem; 2007 Dec; 15(24):7738-45. PubMed ID: 17870541
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Informing mechanistic toxicology with computational molecular models.
    Goldsmith MR; Peterson SD; Chang DT; Transue TR; Tornero-Velez R; Tan YM; Dary CC
    Methods Mol Biol; 2012; 929():139-65. PubMed ID: 23007429
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combinatorial QSAR modeling of chemical toxicants tested against Tetrahymena pyriformis.
    Zhu H; Tropsha A; Fourches D; Varnek A; Papa E; Gramatica P; Oberg T; Dao P; Cherkasov A; Tetko IV
    J Chem Inf Model; 2008 Apr; 48(4):766-84. PubMed ID: 18311912
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structural ensemble in computational drug screening.
    Fukunishi Y
    Expert Opin Drug Metab Toxicol; 2010 Jul; 6(7):835-49. PubMed ID: 20465522
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative evaluation of in silico systems for ames test mutagenicity prediction: scope and limitations.
    Hillebrecht A; Muster W; Brigo A; Kansy M; Weiser T; Singer T
    Chem Res Toxicol; 2011 Jun; 24(6):843-54. PubMed ID: 21534561
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Computational toxicology--a state of the science mini review.
    Kavlock RJ; Ankley G; Blancato J; Breen M; Conolly R; Dix D; Houck K; Hubal E; Judson R; Rabinowitz J; Richard A; Setzer RW; Shah I; Villeneuve D; Weber E
    Toxicol Sci; 2008 May; 103(1):14-27. PubMed ID: 18065772
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictive tools for the evaluation of microbial effects on drugs during gastrointestinal passage.
    Pieper IA; Bertau M
    Expert Opin Drug Metab Toxicol; 2010 Jun; 6(6):747-60. PubMed ID: 20367108
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Computational medicinal chemistry in fragment-based drug discovery: what, how and when.
    Rabal O; Urbano-Cuadrado M; Oyarzabal J
    Future Med Chem; 2011 Jan; 3(1):95-134. PubMed ID: 21428828
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Accessing, using, and creating chemical property databases for computational toxicology modeling.
    Williams AJ; Ekins S; Spjuth O; Willighagen EL
    Methods Mol Biol; 2012; 929():221-41. PubMed ID: 23007432
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Computational toxicology approaches at the US Food and Drug Administration.
    Yang C; Valerio LG; Arvidson KB
    Altern Lab Anim; 2009 Nov; 37(5):523-31. PubMed ID: 20017581
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Toxicophore exploration as a screening technology for drug design and discovery: techniques, scope and limitations.
    Singh PK; Negi A; Gupta PK; Chauhan M; Kumar R
    Arch Toxicol; 2016 Aug; 90(8):1785-802. PubMed ID: 26341667
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Troubleshooting computational methods in drug discovery.
    Kortagere S; Ekins S
    J Pharmacol Toxicol Methods; 2010; 61(2):67-75. PubMed ID: 20176118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.